KRAS and non-small cell lung carcinoma: KRAS mutations are among the most common activating mutations found in tumors, frequently present in non-small cell lung cancer (NSCLC), pancreatic ductal adenocarcinoma (PDAC), endometrial carcinoma, and colorectal carcinoma (CRC).